GTX Medical and NeuroRecovery Technologies today announced their merger into a global company for the development of neuromodulation therapies for spinal cord injuries.
The two merging companies plan to develop the targeted epidural spine stimulation system, an implantable spinal cord stimulation platform designed to restore locomotion in patients with spinal cord injury with real-time motion feedback.
There is also a second, non-invasive product in the works, as a transcutaneous spinal cord stimulation system is in development for the restoration of upper limb movement and hand function.
SPINAL CORD INJURY RESEARCH AND SCIENCE 
Give us more live results from your medical trials. Thank you.
So exciting. Hope for the previous hopeless! God is good!
this sounds amazing! i wonder if it will work for neurogenic bladder??